Comparison of Triple Anti-Platelet Therapy and Dual Anti-Platelet Therapy in Patients With Acute Myocardial Infarction Who Had No-Reflow Phenomenon During Percutaneous Coronary InterventionKi Hong Lee, Hae Chang Jeong, Keun Ho Park et al.|Circulation Journal|2013Cited by 14
Clinical impacts of inhibition of renin–angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary interventionPark Hyukjin, Joo Young Yang, Hyun Kuk Kim et al.|Journal of Cardiology|2016Cited by 13
Clinical experience with primary cardiac tumorsWon Jae Lee, Byung Chun Jung, Hyun Su Jo et al.|The Korean Journal of Internal Medicine|2010Cited by 0
Two-year Clinical Outcomes Following Everolimus-eluting Stent Use for Off-label Versus On-label Indications: From the Korean Multicenter Drug-eluting Stent Registry.Jong Yop Pae, Kwon Bae Kim, Cheol Hyun Lee et al.|Unknown|2018Cited by 0